PepVax Email Format
Biotechnology ResearchMaryland, United States1 Employees
PepVax is a biotechnology company focused on developing a DNA-based drug delivery and development platform. Its approach centers on enabling cells within the patient to produce therapeutic proteins, T-cells, and antibodies, with the aim of treating cancers, infectious diseases, and genetic conditions. The company emphasizes a fully synthetic method for producing plasmid vector particles to support mammalian cell transduction, positioning its technology as a way to shift manufacturing from outside the patient to inside, using the patient’s own cells.